[HTML][HTML] Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy

MF Rasul, BM Hussen, A Salihi, BS Ismael, PJ Jalal… - Molecular Cancer, 2022 - Springer
CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats-associated protein
9) shows the opportunity to treat a diverse array of untreated various genetic and …

Diagnosis, prognosis, and treatment of canine hemangiosarcoma: a review based on a consensus organized by the Brazilian association of veterinary oncology …

AB De Nardi, C de Oliveira Massoco Salles Gomes… - Cancers, 2023 - mdpi.com
Simple Summary Hemangiosarcoma is a mesenchymal neoplasm that originates in the
endothelial cells of blood vessels. According to the location of origin, they can be classified …

Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics

L Rodrigues, J Watson, Y Feng, B Lewis, G Harvey… - Scientific Reports, 2023 - nature.com
Naturally occurring canine cancers have remarkable similarities to their human counterparts.
To better understand these similarities, we investigated 671 client-owned dogs from 96 …

Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs

K Wu, L Rodrigues, G Post, G Harvey, M White… - NPJ Precision …, 2023 - nature.com
Spontaneous tumors in canines share significant genetic and histological similarities with
human tumors, positioning them as valuable models to guide drug development. However …

Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous …

S Yoshimoto, N Chester, A Xiong, E Radaelli, H Wang… - MAbs, 2023 - Taylor & Francis
ABSTRACT PD-1 checkpoint inhibitors have revolutionized the treatment of patients with
different cancer histologies including melanoma, renal cell carcinoma, and non-small cell …

Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology

CA London, H Gardner, S Zhao… - Veterinary and …, 2023 - Wiley Online Library
Pet dogs develop spontaneous cancers at a rate estimated to be five times higher than that
of humans, providing a unique opportunity to study disease biology and evaluate novel …

Cancer-immunity cycle and therapeutic interventions-opportunities for including pet dogs with cancer

SK Von Rueden, TM Fan - Frontiers in Oncology, 2021 - frontiersin.org
The tumor-immune interplay represents a dynamic series of events executed by cellular and
soluble participants that either promote or inhibit successful tumor formation and growth …

Cancer immunotherapy

N Mason, S Dow - Therapeutic Strategies in Veterinary …, 2023 - cabidigitallibrary.org
7 Nuclear Transport Inhibitors Page 1 7 Nuclear Transport Inhibitors CHERYL LONDON* Tufts
University, North Grafton, Massachusetts, USA Introduction: Regulation of Nuclear Transport The …

Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials

KT Kleber, KR Iranpur, LM Perry, SM Cruz… - Frontiers in …, 2022 - frontiersin.org
The microbiome has clearly been established as a cutting-edge field in tumor immunology
and immunotherapy. Growing evidence supports the role of the microbiome in immune …

Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs

J Watson, T Wang, KL Ho, Y Feng, T Mahawan… - Breast Cancer …, 2023 - Springer
Background About 20% of breast cancers in humans are basal-like, a subtype that is often
triple-negative and difficult to treat. An effective translational model for basal-like breast …